Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57442 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2010-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2013-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2013507904-A |
titleOfInvention |
Method and kit for use in cancer risk assessment |
abstract |
Disclosed is a method for assessing the risk of endometrial cancer recurrence based on the presence or absence of a mutation in FGFR2. [Selection] Figure 1 |
priorityDate |
2009-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |